This analysis confirmed the presence of PRDX6 in plasma, which to our knowledge has not been reported before, and also revealed higher plasma PRDX6 levels in AAA patients than in controls (21 ± 2 vs 10 ± 2 ng/mL; p < 0.01) (Fig. 7a). The gene discussed is PRDX6; the disease is triple-A syndrome.